KR20050061490A - 티에노피롤 유도체의 제조 방법과 중간체 - Google Patents

티에노피롤 유도체의 제조 방법과 중간체 Download PDF

Info

Publication number
KR20050061490A
KR20050061490A KR1020057005374A KR20057005374A KR20050061490A KR 20050061490 A KR20050061490 A KR 20050061490A KR 1020057005374 A KR1020057005374 A KR 1020057005374A KR 20057005374 A KR20057005374 A KR 20057005374A KR 20050061490 A KR20050061490 A KR 20050061490A
Authority
KR
South Korea
Prior art keywords
alkyl
formula
amino
carbamoyl
compound
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
KR1020057005374A
Other languages
English (en)
Korean (ko)
Inventor
마이클 버터스
폴 스코필드
앤드류 스토컬
Original Assignee
아스트라제네카 아베
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 아스트라제네카 아베 filed Critical 아스트라제네카 아베
Publication of KR20050061490A publication Critical patent/KR20050061490A/ko
Withdrawn legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D495/00Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04Ortho-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D333/00Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/26Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D333/30Hetero atoms other than halogen
    • C07D333/36Nitrogen atoms
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Heterocyclic Compounds Containing Sulfur Atoms (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
KR1020057005374A 2002-10-03 2003-09-29 티에노피롤 유도체의 제조 방법과 중간체 Withdrawn KR20050061490A (ko)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB0222909.4 2002-10-03
GBGB0222909.4A GB0222909D0 (en) 2002-10-03 2002-10-03 Novel process and intermediates

Publications (1)

Publication Number Publication Date
KR20050061490A true KR20050061490A (ko) 2005-06-22

Family

ID=9945217

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020057005374A Withdrawn KR20050061490A (ko) 2002-10-03 2003-09-29 티에노피롤 유도체의 제조 방법과 중간체

Country Status (13)

Country Link
US (1) US7307174B2 (https=)
EP (1) EP1549653A1 (https=)
JP (1) JP2006503077A (https=)
KR (1) KR20050061490A (https=)
CN (1) CN1688588A (https=)
AU (1) AU2003267656A1 (https=)
BR (1) BR0314312A (https=)
CA (1) CA2498843A1 (https=)
GB (1) GB0222909D0 (https=)
MX (1) MXPA05003387A (https=)
NO (1) NO20051047L (https=)
WO (1) WO2004031193A1 (https=)
ZA (1) ZA200501742B (https=)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0205175D0 (en) 2002-03-06 2002-04-17 Astrazeneca Ab Chemical compounds
GB0205166D0 (en) 2002-03-06 2002-04-17 Astrazeneca Ab Chemical compounds
GB0205176D0 (en) 2002-03-06 2002-04-17 Astrazeneca Ab Chemical compounds
GB0205165D0 (en) 2002-03-06 2002-04-17 Astrazeneca Ab Chemical compounds
GB0205162D0 (en) 2002-03-06 2002-04-17 Astrazeneca Ab Chemical compounds
GB0205170D0 (en) 2002-03-06 2002-04-17 Astrazeneca Ab Chemical compounds
GB0222912D0 (en) 2002-10-03 2002-11-13 Astrazeneca Ab Novel process and intermediates
GB0321003D0 (en) * 2003-09-09 2003-10-08 Angeletti P Ist Richerche Bio Compounds, compositions and uses
AU2004312530A1 (en) 2003-12-29 2005-07-21 Sepracor Inc. Pyrrole and pyrazole DAAO inhibitors
NZ569608A (en) 2006-01-06 2011-09-30 Sepracor Inc Tetralone-based monoamine reuptake inhibitors
BRPI0706365A2 (pt) 2006-01-06 2011-03-22 Sepracor Inc Cicloalquilaminas como inibidores da recaptação de monoamina
US7884124B2 (en) 2006-06-30 2011-02-08 Sepracor Inc. Fluoro-substituted inhibitors of D-amino acid oxidase
MX2009007395A (es) * 2007-01-09 2009-07-17 Bayer Schering Pharma Ag Marcacion radioactiva por fluoracion de aziridinas.
US7902252B2 (en) 2007-01-18 2011-03-08 Sepracor, Inc. Inhibitors of D-amino acid oxidase
AU2008259841B2 (en) 2007-05-31 2015-02-05 Sunovion Pharmaceuticals Inc. Phenyl substituted cycloalkylamines as monoamine reuptake inhibitors
CN106588868A (zh) * 2016-11-16 2017-04-26 武汉理工大学 一种2‑溴‑3‑噻吩甲酸中间体的合成方法

Family Cites Families (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SU364613A1 (ru) 1970-11-27 1972-12-28 Всесоюзный научно исследовательский химико фармацевтический институт имени С. Орджоникидзе Способ получения производных 2-аминотиено-
GB9302622D0 (en) 1993-02-10 1993-03-24 Wellcome Found Heteroaromatic compounds
ATE257480T1 (de) 1999-09-30 2004-01-15 Pfizer Prod Inc Bicyclische pyrrolylamide als glycogenphosphorylase-inhibitoren
AU778042B2 (en) 1999-10-19 2004-11-11 Merck & Co., Inc. Tyrosine kinase inhibitors
SE9903998D0 (sv) 1999-11-03 1999-11-03 Astra Ab New compounds
JP2001294572A (ja) 2000-02-09 2001-10-23 Dai Ichi Seiyaku Co Ltd 新規スルホニル誘導体
EP1136071A3 (en) 2000-03-22 2003-03-26 Pfizer Products Inc. Use of glycogen phosphorylase inhibitors
GB0017676D0 (en) * 2000-07-19 2000-09-06 Angeletti P Ist Richerche Bio Inhibitors of viral polymerase
GB0021831D0 (en) 2000-09-06 2000-10-18 Astrazeneca Ab Chemical compounds
MXPA03000966A (es) 2002-02-28 2003-09-04 Pfizer Prod Inc Agentes antidiabeticos.
GB0205175D0 (en) 2002-03-06 2002-04-17 Astrazeneca Ab Chemical compounds
GB0205165D0 (en) 2002-03-06 2002-04-17 Astrazeneca Ab Chemical compounds
GB0205166D0 (en) 2002-03-06 2002-04-17 Astrazeneca Ab Chemical compounds
GB0205162D0 (en) 2002-03-06 2002-04-17 Astrazeneca Ab Chemical compounds
GB0205176D0 (en) 2002-03-06 2002-04-17 Astrazeneca Ab Chemical compounds
GB0205170D0 (en) 2002-03-06 2002-04-17 Astrazeneca Ab Chemical compounds
WO2003091213A1 (en) 2002-04-25 2003-11-06 Yamanouchi Pharmaceutical Co., Ltd. Novel amide derivatives or salts thereof
EP1543011B1 (en) 2002-09-06 2006-05-03 Janssen Pharmaceutica N.V. Thienopyrrolyl and furanopyrrolyl compounds and their use as histamine h4 receptor ligands
GB0222912D0 (en) 2002-10-03 2002-11-13 Astrazeneca Ab Novel process and intermediates
CA2503727A1 (en) 2002-11-07 2004-05-21 Pfizer Products Inc. Anti-diabetic agents
US7098235B2 (en) 2002-11-14 2006-08-29 Bristol-Myers Squibb Co. Triglyceride and triglyceride-like prodrugs of glycogen phosphorylase inhibiting compounds
JP2004196702A (ja) 2002-12-18 2004-07-15 Yamanouchi Pharmaceut Co Ltd 新規なアミド誘導体又はその塩
ES2393996T3 (es) 2002-12-25 2013-01-04 Daiichi Sankyo Company, Limited Derivados de diaminociclohexano antitrombóticos
EP1620427A1 (en) 2003-04-17 2006-02-01 Pfizer Products Inc. Carboxamide derivatives as anti-diabetic agents
WO2004096768A1 (en) 2003-04-30 2004-11-11 Pfizer Products Inc. Anti-diabetic agents
WO2004113345A1 (ja) 2003-06-20 2004-12-29 Japan Tobacco Inc. 縮合ピロール化合物及びその医薬用途
GB0318464D0 (en) 2003-08-07 2003-09-10 Astrazeneca Ab Chemical compounds
GB0318463D0 (en) 2003-08-07 2003-09-10 Astrazeneca Ab Chemical compounds
GB0319690D0 (en) 2003-08-22 2003-09-24 Astrazeneca Ab Chemical compounds
GB0319759D0 (en) 2003-08-22 2003-09-24 Astrazeneca Ab Chemical compounds
WO2005020985A1 (en) 2003-08-29 2005-03-10 Astrazeneca Ab Indolamide derivatives which possess glycogen phosphorylase inhibitory activity
WO2005020986A1 (en) 2003-08-29 2005-03-10 Astrazeneca Ab Heterocyclic amide derivatives which posses glycogen phosphorylase inhibitory activity
GB0320422D0 (en) 2003-08-30 2003-10-01 Astrazeneca Ab Chemical compounds

Also Published As

Publication number Publication date
AU2003267656A1 (en) 2004-04-23
JP2006503077A (ja) 2006-01-26
WO2004031193A1 (en) 2004-04-15
EP1549653A1 (en) 2005-07-06
CA2498843A1 (en) 2004-04-15
US20050272938A1 (en) 2005-12-08
GB0222909D0 (en) 2002-11-13
CN1688588A (zh) 2005-10-26
MXPA05003387A (es) 2005-06-22
US7307174B2 (en) 2007-12-11
ZA200501742B (en) 2006-03-29
BR0314312A (pt) 2005-07-26
NO20051047L (no) 2005-04-28

Similar Documents

Publication Publication Date Title
KR20050061490A (ko) 티에노피롤 유도체의 제조 방법과 중간체
KR20040027878A (ko) 아미딘 유도체의 제조 방법
US5541329A (en) Intermediates prepared in an asymmetric total synthesis of camptothecin analogs
JPWO1999051586A1 (ja) 一重項酸素測定用試薬
KR20050061503A (ko) 티에노피롤 유도체의 제조 방법과 중간체
FI78084C (fi) Foerfarande foer framstaellning av nya, terapeutiskt verksamma bensopyranderivat.
CA1053674A (en) Fused pyridine-4-(3h)-ones and preparation thereof
JPH07285920A (ja) 新規なアミノカルボン酸エステル及びその製法
CA1219264A (en) Benzobisoxazinetetrones
SU683618A3 (ru) Способ получени производных бензодиазепина
AU2004326111A1 (en) Process for preparing 5,6-dihydro-4-(S)-(ethylamino)-6-(S) methyl-4H-thieno[2,3b]thiopyran-2-sulphonamide-7,7-dioxide HCI
Abdel-Mohsen et al. Synthesis of pyrido [2′, 3′: 4, 5] thieno [2, 3-d] pyrimidines through Friedländer reactions
KR100856133B1 (ko) 아토르바스타틴의 개선된 제조방법
EA002723B1 (ru) Способы и промежуточные продукты, полезные для получения антифолатов
KR100280925B1 (ko) 2-니트로티오잔톤의 제조방법
JP3961049B2 (ja) 3−アミノ−4−(1−ヒドロキシアルキル)ピラゾリン化合物、その製造方法およびそれを使用した製造方法
JP2711435B2 (ja) 新規な2,3−ジヒドロ−4h−1−ベンゾピラン−4−オン誘導体またはその塩
JPH05148192A (ja) 非対称9−アミノスチリル−10−スチリルアントラセン誘導体ならびにその製造法
PL126876B1 (en) Method of obtaining new alpha-acyloxyacetamides
MXPA00007824A (https=)
JPH072836A (ja) N−チエニルアミノメチレン酢酸誘導体の製造方法
HRP20000279A2 (en) Process for the preparation of sildenaphyl and intermediates
JPS5814437B2 (ja) ピラゾロピリジン −3− カルボンサンユウドウタイノセイゾウホウ
PL198648B1 (pl) Sposób otrzymywania pochodnej benzaldehydu i jej soli oraz nowe półprodukty
JPS5850229B2 (ja) 新規なピリド〔2,3−d〕ピリミジン誘導体の製造体

Legal Events

Date Code Title Description
PA0105 International application

Patent event date: 20050328

Patent event code: PA01051R01D

Comment text: International Patent Application

PG1501 Laying open of application
PC1203 Withdrawal of no request for examination
WITN Application deemed withdrawn, e.g. because no request for examination was filed or no examination fee was paid